SK Bioscience Implements Digital Transformation with BIOVIA ONE Lab
SK Bioscience, a South Korean biotech company, has implemented a clinical Laboratory Information Management System (LIMS) to improve its global competitiveness. The LIMS is based on the BIOVIA ONE Lab platform from Dassault Systèmes and tracks and manages the entire sample process in real time, from specimen receipt to analysis, storage, and export.
According to SK Bioscience, this is the first GCLP clinical trial specimen analysis laboratory in Korea to introduce a LIMS.
SK Bioscience plans to use the LIMS to accelerate its global expansion. The company is targeting advanced bio and vaccine markets in Europe and the United States, where compliance with global regulations and standards is essential. The LIMS will help SK Bioscience to meet these requirements and ensure that its products are competitive in the global marketplace.
Hwang Jae-seon, head of SK Bioscience’s Digital Innovation Department, said, “In order to enter advanced bio and vaccine markets such as Europe and the United States, it is most important to comply with global regulations and standards. Digital capabilities that meet global standards such as LIMS are essential for securing product competitiveness and In addition, it will play an important role in collaborating with various overseas partners.”
The LIMS from BIOVIA provides a number of benefits over manual methods, including:
- Guaranteed data integrity: LIMS ensures that all data is complete, accurate, and consistent.
- Improved efficiency: LIMS automates many tasks, such as report generation, which frees up staff to focus on more important work.
- Enhanced collaboration: LIMS makes it easier to share data and collaborate with colleagues and partners around the world.
A business intelligence (BI) dashboard was also built to analyze the suitability of accumulated data and monitor test progress in real time. Based on this, all processes and results of clinical trial immunogenicity analysis are recorded in real time. Result reports are created automatically, enabling work efficiency and management system to be strengthened at the same time.
In addition to the LIMS, SK Bioscience is also implementing other digital transformation initiatives in its R&D system. These initiatives are aimed at improving the efficiency and productivity of the R&D process, as well as the quality of the data that is generated.
SK Bioscience’s digital transformation efforts are part of a broader trend in the biotechnology industry. More and more biotech companies are adopting digital technologies to improve their operations and gain a competitive advantage. BIOVIA ONE Lab is a comprehensive solution designed to accelerate digital transformation across all different types of labs, streamlining workflows by removing the barriers between traditional solutions such as LIMS, LES, ELNs, and other lab informatics systems. To learn more visit go.3ds.com/onelab
Original article and reporting from etnews.com.